CN108774279A - 6-- 17 α of methylol-acetoxyl group-19- norpregna-4,6- diene-3,20- diketone synthetic methods - Google Patents

6-- 17 α of methylol-acetoxyl group-19- norpregna-4,6- diene-3,20- diketone synthetic methods Download PDF

Info

Publication number
CN108774279A
CN108774279A CN201810541947.1A CN201810541947A CN108774279A CN 108774279 A CN108774279 A CN 108774279A CN 201810541947 A CN201810541947 A CN 201810541947A CN 108774279 A CN108774279 A CN 108774279A
Authority
CN
China
Prior art keywords
norpregna
acetoxyl group
diketone
diene
methylol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810541947.1A
Other languages
Chinese (zh)
Other versions
CN108774279B (en
Inventor
黄云生
王钱钢
张小元
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lijiang Huaying Hormone Drug Technology Development Co Ltd
LIJIANG YINGHUA BIOLOGICAL DRUG CO Ltd
Original Assignee
Lijiang Huaying Hormone Drug Technology Development Co Ltd
LIJIANG YINGHUA BIOLOGICAL DRUG CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lijiang Huaying Hormone Drug Technology Development Co Ltd, LIJIANG YINGHUA BIOLOGICAL DRUG CO Ltd filed Critical Lijiang Huaying Hormone Drug Technology Development Co Ltd
Priority to CN201810541947.1A priority Critical patent/CN108774279B/en
Publication of CN108774279A publication Critical patent/CN108774279A/en
Application granted granted Critical
Publication of CN108774279B publication Critical patent/CN108774279B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention provides a kind of synthetic methods of -17 α of 6- methylols-acetoxyl group -19- norpregna -4,6- diene -3,20- diketone, it is characterized in that(1)By 6-- 17 α of methylene-acetoxyl group-19- norpregna-4- alkene-3,20- diketone(2)It is added in reaction bulb, dichloromethane is added and makes it dissolve, adds metachloroperbenzoic acid, is stirred to react until raw material completely disappears, obtains epoxide 3 and 4 mixtures;(2)Intermediate epoxide 3 and 4 mixtures are dissolved in THF, dilute sulfuric acid is added with stirring, until intermediate completely disappears, dehydration obtains 6-- 17 α of methylol-acetoxyl group-19- norpregnas-4 that product 1 is synthesized using the present invention, 6- diene-3,20- diketone, purity are up to 99.77%.

Description

6-- 17 α of methylol-acetoxyl group-19- norpregna-4,6- diene-3,20- diketone Synthetic method
Technical field
The present invention relates to pharmaceutical synthesis fields, in particular it relates to one kind 6-- 17 α of methylol-acetoxyl group-19- The synthetic method of norpregna -4,6- diene -3,20- diketone.
Background technology
6-- 17 α of methylol-acetoxyl group-19- norpregna-4,6- diene-3,20- diketone is new and effective oral pregnant Another being likely to occur in the analog of hormone Nomegestrol acetate, and the technique of synthesis Nomegestrol acetate is miscellaneous Matter(Impurity B).Nomegestrol acetate is as forth generation contraceptive with contraceptive effect is good, toxic side effect is small, easy to use, peace Congruent feature is applied to contraception, hormone replacement therapy, endometriosis, menoxenia etc. in European countries extensively Various gynaecology's uncomfortable diseases Chinese Pharmacological Bulletin 2004,20 (11), 1215-7;Chinese Journal of New Drugs 2011,20 (19), 1880-1885).Since 6-- 17 α of methylol-acetoxyl group-19- goes first Pregnant steroid -4,6- diene -3,20- diketone be Nomegestrol synthesis in issuable impurity, it is needed carry out technology controlling and process and The detection of final products.Since the content of this impurity in the final product is very low, structure is not reported, and belongs to new chemical combination Object.Therefore, simple preparation 6-- 17 α of methylol-acetoxyl group-19- norpregnas-4,6- diene-3 are researched and developed, The method of 20- diketone, to solve its source extremely important as standard reference material.
Invention content
The goal of the invention of the present invention is to provide 6-- 17 α of methylol of one kind-acetoxyl group-19- norpregna-4,6- diene- The synthetic method of 3,20- diketone solves 6-- 17 α of methylol-acetoxyl group-19- norpregna-4,6- diene-3,20- diketone As standard reference material.
Referring to Fig.1,6-- 17 α of methylol of the invention-acetoxyl group-19- norpregna-4,6- diene-3,20- diketone Synthetic method, include the following steps:
1, by 6-- 17 α of methylene-acetoxyl group-19- norpregna-4- alkene-3,20- diketone(2)It is added in reaction bulb, adds Enter dichloromethane to make it dissolve, add metachloroperbenzoic acid, is stirred to react until raw material completely disappears, obtains epoxy compound Object 3 and 4 mixtures, wherein-17 α of 6-methylene of reactant-acetoxyl group-19- norpregnas-4- alkene-3,20- diketone and The molar ratio of chloroperoxybenzoic acid is 1:1 ~ 1:5, reaction temperature is 0~40 DEG C.
2, intermediate epoxide 3 and 4 mixtures are dissolved in THF, are added with stirring dilute sulfuric acid, until intermediate It completely disappears, dehydration obtains product 1, wherein a concentration of 0.1 ~ 1 N of the sulfuric acid of addition, mole of sulfuric acid and epoxides Ratio is 0.01:1 ~ 0.5:1, reaction temperature is 0 ~ 50 DEG C.
The present invention provides 6-- 17 α of methylol of one kind-acetoxyl group-19- norpregna-4,6- diene-3,20- diketone Synthetic method, 6-- 17 α of methylol-acetoxyl group-19- norpregna-4,6- diene-3,20- diketone is Nomegestrol acetic acid The analogue of ester may have related progestogens activity, and the impurity that may be brought into synthesis Nomegestrol technique. In addition, this compound belongs to noval chemical compound, document is not reported.It is detected through HPLC, the 6-methylols-17 synthesized using the present invention α-acetoxyl group -19- norpregna -4,6- diene -3,20- diketone, purity are up to 99.77%.
Description of the drawings
Fig. 1 is that the synthetic route of 6-- 17 α of methylol-acetoxyl group-19- norpregna-4,6- diene-3,20- diketone is anti- Answer formula.
Fig. 2 is 6-- 17 α of methylol-acetoxyl group-19- norpregna-4,6- diene-3,20- diketone testing results.
Specific implementation mode
Embodiment 1
By 6-- 17 α of methylene-acetoxyl group-19- norpregna-4- alkene-3,20- diketone(1.0 g, 2.7 mmol)It is added to In 25 mL reaction bulbs, dichloromethane is added(5 mL), mCPBA is added at 0 DEG C in stirring and dissolving(1.0 g, 5.8 mmol)'s Dichloromethane(5 mL)Solution is warmed to room temperature and is stirred overnight, and reaction solution is poured into ice water, dichloromethane extraction, respectively with 10% Sodium sulfite aqueous solution, the washing of 10% sodium bicarbonate aqueous solution, anhydrous magnesium sulfate drying filter, it is organic molten that removing are concentrated under reduced pressure Agent, column chromatography for separation obtain epoxidation product(0.35 g, yield 33.3%).
By above-mentioned epoxide(0.35 g, 0.9 mmol)It is added in the reaction bulb of 10mL, tetrahydrofuran is added(5 mL), stirring and dissolving is cooled to 0 DEG C or so, 0.4 N sulfuric acid is added(1 mL, 0.2 mmol), it is stirred overnight at room temperature, by reaction solution It pours into ice water, with dichloromethane extraction, saturated sodium bicarbonate aqueous solution washs, anhydrous magnesium sulfate is dried, and filtering is removed under reduced pressure Organic solvent, column chromatography for separation obtain-17 α of 6-methylol of white solid product-acetoxyl group-19- norpregnas-4,6- bis- Alkene -3,20- diketone(290 nm of 0.12 g, 99.73%@of purity), yield 34%, m. p. DEG C.1H NMR (CDCl3, ppm): δ 6.36 (s, 1H), 6.01 (s, 6.01), 4.32-4.33 (d, 1H), 2.96-3.03 (dt, 1H), 2.55-2.59 (dd, 1H), 2.30-2.35 (m, 3H), 2.16 -2.22 (m, 1H), 2.09 (s, 3H), 2.06 (s, 3H), 1.93-2.02 (m, 4H), 1.55-1.68 (m, 4H), 1.10-1.47 (m, 3H), 0.72 (s, 3H)。DEPT-13C NMR (CDCl3, ppm): δ 139.79 (C-7), 121.43 (C-4), 62.71 (6-CH2-OH), 48.54 (C-14), 45.33 (C-9), 41.01 (C-10), 40.89 (C-8), 37.39 (C-2), 30.99 (C- 12), 30.30 (C-16), 26.85 (C-1), 26.44 (C-21), 24.93 (C-11), 23.18 (C-15), 21.18 (17-OCOCH3), 14.19 (C-18)。MS (ESI): 387.3 (M + H)。
Embodiment 2
By 6-- 17 α of methylene-acetoxyl group-19- norpregna-4- alkene-3,20- diketone(1.0 g, 2.7 mmol)It is added to In 25 mL reaction bulbs, dichloromethane is added(5 mL), mCPBA is added in stirring and dissolving at room temperature(2.0 g, 11.6 mmol)'s Dichloromethane(5 mL)Solution is stirred at room temperature 1 hour, and heating reflux reaction 2 hours pours into reaction solution in ice water, dichloromethane Alkane extracts, and is washed respectively with 10% sodium sulfite aqueous solution, 10% sodium bicarbonate aqueous solution, and anhydrous magnesium sulfate drying filters, decompression Concentration removes organic solvent, is added directly into the reaction bulb of 10 mL after obtaining epoxidation product crude product, is dissolved in tetrahydrofuran (10 mL), it is cooled to 0 DEG C, 1 N sulfuric acid is added(0.5 mL), it is warmed to room temperature stirring 1 hour, 50 DEG C is heated to and reacts 3 hours, Reaction solution is poured into ice water, with dichloromethane extraction, saturated sodium bicarbonate aqueous solution washs, anhydrous magnesium sulfate is dried, filtering, Organic solvent is removed under reduced pressure, column chromatography for separation obtains-17 α of 6-methylol of white solid product-acetoxyl group-19- norpregnas- 4,6- diene -3,20- diketone(290 nm of 0.37 g, 99.5%@of purity), two step gross production rates 35%.
Embodiment 3
By 6-- 17 α of methylene-acetoxyl group-19- norpregna-4- alkene-3,20- diketone(1.0 g, 2.7 mmol)It is added to In 25 mL reaction bulbs, dichloromethane is added(5 mL), mCPBA is added in stirring and dissolving at room temperature(0.5 g, 2.9 mmol)Two Chloromethanes(5 mL)Solution, agitating and heating are refluxed overnight, and reaction solution is poured into ice water, dichloromethane extraction, respectively with 10% Asia Aqueous sodium persulfate solution, the washing of 10% sodium bicarbonate aqueous solution, anhydrous magnesium sulfate drying filter, are concentrated under reduced pressure and remove organic solvent, It is added directly into the reaction bulb of 10 mL after obtaining epoxidation product crude product, is dissolved in tetrahydrofuran(10 mL), it is cooled to 0 DEG C, 0.1 N sulfuric acid is added(2 mL), it was stirred at room temperature 1 as a child, and was reacted 2 hours at 35-40 DEG C, reaction solution is poured into ice water In, with dichloromethane extraction, saturated sodium bicarbonate aqueous solution washs, anhydrous magnesium sulfate is dried, and filtering is removed under reduced pressure organic molten Agent, column chromatography for separation obtain-17 α of 6-methylol of white solid product-acetoxyl group-19- norpregna-4,6- diene-3,20- Diketone(290 nm of 0.29 g, 98.8%@of purity), two step gross production rates 28%.
Embodiment 4
By 6-- 17 α of methylene-acetoxyl group-19- norpregna-4- alkene-3,20- diketone(1.0 g, 2.7 mmol)It is added to In 25 mL reaction bulbs, dichloromethane is added(5 mL), mCPBA is added in stirring and dissolving at room temperature(1.5 g, 8.7 mmol)Two Chloromethanes(5 mL)Solution is stirred to react 1 hour at room temperature, and heating reflux reaction 2 hours pours into reaction solution in ice water, two Chloromethanes extracts, and is washed respectively with 10% sodium sulfite aqueous solution, 10% sodium bicarbonate aqueous solution, and anhydrous magnesium sulfate drying filters, It is concentrated under reduced pressure and removes organic solvent, be added directly into the reaction bulb of 10 mL after obtaining epoxidation product crude product, be dissolved in tetrahydrochysene Furans(10 mL), it is cooled to 0 DEG C, 0.6 N sulfuric acid is added(2 mL), it was stirred at room temperature 1 as a child, and was heated to reflux stirring 2 hours, Reaction solution is poured into ice water, with dichloromethane extraction, saturated sodium bicarbonate aqueous solution washs, anhydrous magnesium sulfate is dried, filtering, Organic solvent is removed under reduced pressure, column chromatography for separation obtains-17 α of 6-methylol of white solid product-acetoxyl group-19- norpregnas- 4,6- diene -3,20- diketone(290 nm of 0.33 g, 99.3%@of purity), two step gross production rates 32%.

Claims (6)

1. a kind of synthetic method of -17 α of 6- methylols-acetoxyl group -19- norpregna -4,6- diene -3,20- diketone, special Sign is
(1)By 6-- 17 α of methylene-acetoxyl group-19- norpregna-4- alkene-3,20- diketone(2)It is added in reaction bulb, adds Enter dichloromethane to make it dissolve, add metachloroperbenzoic acid, is stirred to react until raw material completely disappears, obtains epoxy compound Object 3 and 4 mixtures;
(2)Intermediate epoxide 3 and 4 mixtures are dissolved in THF, dilute sulfuric acid is added with stirring, until intermediate is complete Mistake is totally disappeared, dehydration obtains product 1.
2.-17 α of 6-methylol according to claim 1-acetoxyl group-19- norpregna-4,6- diene-3,20- diketone Synthetic method, it is characterised in that step(1)Reaction temperature be 0~40 DEG C.
3.-17 α of 6-methylol according to claim 1-acetoxyl group-19- norpregna-4,6- diene-3,20- diketone Synthetic method, it is characterised in that step(1)- 17 α of middle 6-methylene of reactant-alkene-3 acetoxyl group-19- norpregna-4-, The molar ratio of 20- diketone and metachloroperbenzoic acid is 1:1 ~ 1:5.
4.-17 α of 6-methylol according to claim 1-acetoxyl group-19- norpregna-4,6- diene-3,20- diketone Synthetic method, it is characterised in that step(2)The middle sulfuric acid concentration used is 0.1 ~ 1 N.
5.-17 α of 6-methylol according to claim 1-acetoxyl group-19- norpregna-4,6- diene-3,20- diketone Synthetic method, it is characterised in that step(2)The molar ratio of middle sulfuric acid and epoxides is 0.01:1 ~ 0.5:1.
6.-17 α of 6-methylol according to claim 1-acetoxyl group-19- norpregna-4,6- diene-3,20- diketone Synthetic method, it is characterised in that step(2)Reaction temperature be 0~50 DEG C.
CN201810541947.1A 2018-05-30 2018-05-30 Synthesis method of 6-hydroxymethyl-17 alpha-acetoxyl-19-norpregna-4, 6-diene-3, 20-diketone Active CN108774279B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810541947.1A CN108774279B (en) 2018-05-30 2018-05-30 Synthesis method of 6-hydroxymethyl-17 alpha-acetoxyl-19-norpregna-4, 6-diene-3, 20-diketone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810541947.1A CN108774279B (en) 2018-05-30 2018-05-30 Synthesis method of 6-hydroxymethyl-17 alpha-acetoxyl-19-norpregna-4, 6-diene-3, 20-diketone

Publications (2)

Publication Number Publication Date
CN108774279A true CN108774279A (en) 2018-11-09
CN108774279B CN108774279B (en) 2021-01-19

Family

ID=64028034

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810541947.1A Active CN108774279B (en) 2018-05-30 2018-05-30 Synthesis method of 6-hydroxymethyl-17 alpha-acetoxyl-19-norpregna-4, 6-diene-3, 20-diketone

Country Status (1)

Country Link
CN (1) CN108774279B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795884A (en) * 1991-07-18 1998-08-18 Laboratoire Theramex Sa 3-keto-nor-pregnenes substituted in the 6-position and treatment of menopause

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795884A (en) * 1991-07-18 1998-08-18 Laboratoire Theramex Sa 3-keto-nor-pregnenes substituted in the 6-position and treatment of menopause

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
C. COMBES等: "Crystal growth and structure of a new hormonal derived compound", 《INTERNATIONAL JOURNAL OF PHARMACEUTICS》 *
DAVID CLEMENTE-TEJEDA等: "Oxidation of unsaturated steroid ketones with hydrogen peroxide catalyzed by Fe(bpmen)(OTf)2. New methodology to access biologically active steroids by chemo-, and stereoselective processes", 《TETRAHEDRON》 *
WILLIAMS . JOHNSON等: "Studies Relating to the Formation and Reactions of Glycidic Esters", 《FORMATIAONDN R EACTIONOSF GLYCIDICE STERS》 *

Also Published As

Publication number Publication date
CN108774279B (en) 2021-01-19

Similar Documents

Publication Publication Date Title
CN101279997B (en) Novel preparation of budesonide
ES2355982T3 (en) PROCEDURE FOR THE PREPARATION OF DROSPIRENONE.
CN105315320B (en) A kind of method preparing shellfish cholic acid difficult to understand
CN104130212B (en) A kind of applicable hydrobromic acid irrigates the synthetic method for western spit of fland industrialized production
CN107312055A (en) A kind of new preparation method of rocuronium
CN109912676A (en) A kind of preparation method of 3 β-ursodesoxycholic acid
CN106397519A (en) Preparation method of altrenogest
CN103864802B (en) The preparation method of maleic acid asenapine
CN106810555B (en) A method of matrine being prepared by oxymatrine using metallic reducing agent
CN108774279A (en) 6-- 17 α of methylol-acetoxyl group-19- norpregna-4,6- diene-3,20- diketone synthetic methods
CN109796461A (en) A kind of preparation process of Tadalafei impurity I
CN109384824A (en) Desogestrel intermediate and preparation method thereof
CN110950920A (en) Preparation method of tetraeestrone
CN103373956B (en) Method for preparing clevidipine butyrate
ITMI952735A1 (en) PROCESS OF PREPARATION OF 2-BETA, 16-BETA-DIAMINO 3-ALPHA, 17-BETA-DIACYLOSS 5-ALPHAANDROSTANS, STRUCTURED NEUROMUSCULAR BLOCKERS
CN102659638B (en) Synthetic method of leonurine
CN104725460A (en) Preparation method of androst-4-ene-6beta,19-epoxy-3,17-dione
CN107383137A (en) A kind of synthetic method of chenodeoxycholic acid
CN107200763A (en) A kind of method using chenodeoxycholic acid as Material synthesis lithocholic acid
CN107021991A (en) A kind of preparation method of 16 β methyl steroids
CN104557965B (en) Preparation technology for beta-artemether
CN110078785A (en) A kind of synthetic method of budesonide impurity E P-ZE
CN102659639B (en) Preparation technology of leonurine
CN108129525B (en) A kind of preparation method of Etoposide intermediate
CN106810585B (en) A kind of -17 α of 6 Alpha-Methyl-acetoxyl group -19- norpregna -4- alkene -3,20- diketone synthetic method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant